Topic

Anke Mueller-Fahrnow

Technology & Infrastructure · Models & LLMs

Conscience Launches to Use AI, Open Science to Tackle Drug Discovery And Development

Insider Brief Conscience is a non-profit venture that uses artificial intelligence and team-work science to enable drug discoveries for diseases. Conscience seeks to lead global drug discovery and development for emerging, rare or complex

9 Oct 2023 · 5 min read

Anke Mueller-Fahrnow

Conscience Launches to Use AI, Open Science to Tackle Drug Discovery And Development

Trending today

Eka Robotics Raises $150M Series A to Scale Vision-Force-Action Model for Dexterous Robots

DeepSeek Secures Reported $15B Days After U.S. Federal Ban

Inovia Capital Secures $200M First Close for AI-Focused Sixth Venture Fund

Germany’s Agile Robots Launches Agile ONE SN Humanoid Research Platform Built on Nvidia GR00T

Pigment Raises $250M at $2.3B Valuation

Anke Mueller-Fahrnow

Conscience Launches to Use AI, Open Science to Tackle Drug Discovery And Development

Trending today

Eka Robotics Raises $150M Series A to Scale Vision-Force-Action Model for Dexterous Robots

DeepSeek Secures Reported $15B Days After U.S. Federal Ban

Inovia Capital Secures $200M First Close for AI-Focused Sixth Venture Fund

Germany’s Agile Robots Launches Agile ONE SN Humanoid Research Platform Built on Nvidia GR00T

Pigment Raises $250M at $2.3B Valuation

The AI economy, every weekday morning